Journal article icon

Journal article

From risk to fairness.

Abstract:

Kadcyla is a drug that extends the life of breast cancer patients by an average of 6 mo. It also happens to be incredibly expensive. The United Kingdom’s National Health Service sparked controversy when it refused to provide this drug to patients, citing its low cost effectiveness. Cases like this raise the question of how societies should make distributive decisions. Should we maximize utility or should we aim to improve the lives of the least fortunate, even if doing so is costly for everyo...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1073/pnas.1614111113

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Experimental Psychology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
HUMS
Department:
Philosophy Faculty
Role:
Author
More by this author
Institution:
University of Oxford
Oxford college:
Jesus College
Role:
Author
Publisher:
National Academy of Sciences Publisher's website
Journal:
Proceedings of the National Academy of Sciences Journal website
Volume:
113
Issue:
42
Pages:
11651-11653
Publication date:
2016-10-01
DOI:
EISSN:
1091-6490
ISSN:
0027-8424
Source identifiers:
655675
Language:
English
Keywords:
Pubs id:
pubs:655675
UUID:
uuid:6d2a4c63-fc96-4eea-858e-456e36b6cc4d
Local pid:
pubs:655675
Deposit date:
2017-06-27

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP